Article
Opioids Confer Risk without Improved Pain Control
March 1, 2024
Clinical question: How effective and safe are opioids for the treatment of acute, non-specific low back and neck pain? Background: Despite the lack of evidence of the effectiveness of opioids for...
Article
Bridging the Gap: How Do You Interpret an Osmolal Gap?
November 1, 2023
Case A 53-year-old man with chronic kidney disease on hemodialysis presented with abdominal pain, nausea, and vomiting. He drinks three to 12 beers daily and denied ingestion of toxic alcohol. Labs...
Article
A High Yield Review of Cannabinoid Hyperemesis Syndrome
November 1, 2023
Dr. Berry Presenters: Rebecca M. Cantu, MD, MPH, Brittany M. Slagle, DO, and Sara Sanders, MD The overall prevalence of cannabinoid hyperemesis syndrome (CHS) is 0.1% and is more common in young...
Article
Crystal, Cake, and K2: What Teens are Smoking, Snorting, Shooting, and Swallowing
November 1, 2023
Dr. Owerko Presenters: Paul Scalici, MD, Meghan Hofto, MD, MPH, DTMH, Lauren Nassetta, MD, James Gambrell, MD During this PHM 2023 session, four pediatric hospitalists tackled a broad topic that...
Article
Emerging Threat: Illicit Drugs Adulterated with Xylazine
September 1, 2023
Xylazine is a semi-synthetic, non-opioid, sedative paralytic used in veterinary medicine as a tranquilizer. It’s an alpha agonist, similar in chemical structure to clonidine and dexmetomidine.1 It...
Article
Acute Pain Management
July 5, 2023
This case-based session provided hospitalists with expert opinions and evidence-based approaches to navigate challenges when managing acute pain in the inpatient setting. Opioid prescription...
Article
Buprenorphine 101: A Quick Start Guide for Every Hospitalist
July 5, 2023
In this workshop, the presenters provided an overview of the diagnosis and management of opioid use disorder (OUD) and an introduction to medication for opioid use disorders (MOUD). The presenters...
Article
Complying with the MATE Act
June 13, 2023
The Medication Access and Training Expansion (MATE) Act is part of the Consolidated Appropriations Act, of 2023, which takes effect June 2023. The MATE Act requires training for Drug Enforcement...
Article
Using Naltrexone for AUD is Safe in Patients With and Without Liver Disease
June 1, 2023
Dr. Hoang Clinical question: Is naltrexone hepatically safe for the treatment of alcohol use disorder (AUD) in patients with and without liver disease? Background: Treatment of underlying AUD...
Article
Implementation of a Comprehensive Hospitalist-led Initiative to Improve Care for Patients with OUD
May 1, 2023
Clinical question: Can a multidisciplinary, hospitalist-led program improve care for hospitalized patients with opioid use disorder (OUD)? Background: Despite rising opioid-related hospitalizations...